CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | TYNDALL JOSEPH A. Director | Sale 10b5-1 | −3,500 | $49.70 | $174K | 10,650 |
| 2026-06-24 | TYNDALL JOSEPH A. Director | Grant or award · Restricted Stock Units | +4,392 | 4,392 | ||
| 2026-06-19 | TYNDALL JOSEPH A. Director | Option exercise | +14,150 | 14,150 | ||
| 2026-06-19 | TYNDALL JOSEPH A. Director | Option exercise · Restricted Stock Units | +14,150 | 0 | ||
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise | +14,248 | $7.04 | $100K | 14,248 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise | +10,860 | $10.95 | $119K | 25,108 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Sale | −14,248 | $30.98 | $441K | 10,860 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Sale | −10,860 | $30.98 | $336K | 0 |
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise · Employee Stock Option (right to purchase) | −14,248 | 0 | ||
| 2025-12-09 | TYNDALL JOSEPH A. Director | Option exercise · Stock Option (right to purchase) | −10,860 | 32,311 | ||
| 2025-06-19 | TYNDALL JOSEPH A. Director | Grant or award · Restricted Stock Units | +14,150 | 14,150 | ||
| 2025-06-10 | TYNDALL JOSEPH A. Director | Option exercise | +7,586 | $6.30 | $48K | 22,931 |
| 2025-06-10 | TYNDALL JOSEPH A. Director | Option exercise | +4,000 | $7.04 | $28K | 26,931 |
| 2025-06-10 | TYNDALL JOSEPH A. Director | Sale | −26,931 | $10.72 | $289K | 0 |
| 2025-06-10 | TYNDALL JOSEPH A. Director | Option exercise · Stock Option (right to purchase) | −7,586 | $6.30 | $48K | 0 |
| 2025-06-10 | TYNDALL JOSEPH A. Director | Option exercise · Employee Stock Option (right to purchase) | −4,000 | $7.04 | $28K | 14,248 |
| 2025-05-22 | TYNDALL JOSEPH A. Director | Option exercise | +12,850 | $6.30 | $81K | 35,407 |
| 2025-05-22 | TYNDALL JOSEPH A. Director | Sale | −12,850 | $11.20 | $144K | 22,557 |
| 2025-05-22 | TYNDALL JOSEPH A. Director | Sale | −7,212 | $11.20 | $81K | 15,345 |
| 2025-05-22 | TYNDALL JOSEPH A. Director | Option exercise · Stock Option (right to purchase) | −12,850 | $6.30 | $81K | 7,586 |
Page 1 of 2 · 28 trades